Millipore Sigma Vibrant Logo

435300 LFM-A13 - CAS 62004-35-7 - Calbiochem

A potent, cell-permeable, reversible, substrate competitive, and specific inhibitor of Bruton's Tyrosine Kinase (BTK; IC₅₀ = 17.2 µM for human BTK in vitro and IC₅₀ = 2.5 µM for recombinant BTK).

LFM-A13 - CAS 62004-35-7 - Calbiochem: MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.

Sinonimi: α-Cyano-β-hydroxy-β-methyl-N-(2,5-dibromophenyl)propenamide, BTK Inhibitor I, Bruton's Tyrosine Kinase Inhibitor I

Primary Target: Human Bruton's Tyrosine Kinase (BTK)
View Products on Sigmaaldrich.com
435300
Visualizza prezzi e disponibilità

Panoramica

Replacement Information

Tabella delle specifiche principali

CAS #Empirical Formula
62004-35-7C₁₁H₈Br₂N₂O₂

Prezzi e disponibilità

Numero di catalogo DisponibilitàConfezionamento Qtà/conf Prezzo Quantità
435300-5MG
Verifica della disponibilità in corso...
—
Disponibilità limitata Disponibilità limitata
A magazzino 
Fuori produzione
Disponibili quantità limitate
La disponibilità deve essere confermata
    Prodotti rimanenti: riceverà un nostro avviso
      Prodotti rimanenti: riceverà un nostro avviso
      Will advise
      Contatti il Servizio Clienti
      Contact Customer Service

      		 Fiala di plastica 5 mg
      Ricerca del prezzo in corso...
      Non è stato possibile trovare il prezzo
      La quantità minima deve essere un multiplo di
      Maximum Quantity is
      Al termine dell'ordine Maggiori informazioni
      Lei ha salvato ()
       
      —
      Richiedi il prezzo
      		 —
      Description
      OverviewA potent, cell-permeable, reversible, substrate competitive, and specific inhibitor of Bruton’s Tyrosine Kinase (BTK; IC50 = 17.2 µM for human BTK in vitro and IC50 = 2.5 µM for recombinant BTK). Also inhibits Polo-like kinase in an ATP-competitive manner (IC50 = 10 µM and 61 µM for Plx1 and Plk3, respectively), and displays antitumor properties. Does not affect the enzymatic activity of other protein tyrosine kinases, including EGFR, HCK, IRK JAK1, and JAK3 even at concentrations of 278 µM. Enhances the chemosensitivity of BTK-positive B-lineage leukemia cells to ceramide- and vincristine-induced apoptosis.
      Catalogue Number435300
      Brand Family Calbiochem®
      Synonymsα-Cyano-β-hydroxy-β-methyl-N-(2,5-dibromophenyl)propenamide, BTK Inhibitor I, Bruton's Tyrosine Kinase Inhibitor I
      References
      ReferencesUckun, F.M., et al. 2006. Bioorg. Med. Chem. In press.
      Mahajan, S., et al. 1999. J. Biol. Chem. 274, 9587.
      Vassilev, A., et al. 1999. J. Biol. Chem. 274, 1646.
      Product Information
      CAS number62004-35-7
      ATP CompetitiveY
      FormLight brown solid
      Hill FormulaC₁₁H₈Br₂N₂O₂
      Chemical formulaC₁₁H₈Br₂N₂O₂
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetHuman Bruton's Tyrosine Kinase (BTK)
      Primary Target IC<sub>50</sub>17.2 µM for human BTK in vitro and 2.5 µM for recombinant BTK
      Purity≥97% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Numero di catalogo GTIN
      435300-5MG 04055977210293

      Documentation

      LFM-A13 - CAS 62004-35-7 - Calbiochem MSDS

      Titolo

      Scheda di sicurezza (MSDS) 

      LFM-A13 - CAS 62004-35-7 - Calbiochem Certificati d'Analisi

      TitoloNumero di lotto
      435300

      Riferimenti bibliografici

      Panoramica delle referenze
      Uckun, F.M., et al. 2006. Bioorg. Med. Chem. In press.
      Mahajan, S., et al. 1999. J. Biol. Chem. 274, 9587.
      Vassilev, A., et al. 1999. J. Biol. Chem. 274, 1646.

      Citazioni

      Titolo
    • Sarah L Doyle, Caroline A Jefferies and Luke A O'Neill. (2005) Bruton's tyrosine kinase is involved in p65-mediated transactivation and phosphorylation of p65 on serine 536 during NF-B activation by LPS. Journal of Biological Chemistry 280, 23496-23501.
      		•
      Scheda tecnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision12-January-2010 RFH
      Synonymsα-Cyano-β-hydroxy-β-methyl-N-(2,5-dibromophenyl)propenamide, BTK Inhibitor I, Bruton's Tyrosine Kinase Inhibitor I
      DescriptionA potent, cell-permeable, reversible, substrate competitive, and specific inhibitor of Bruton's tyrosine kinase (BTK; IC50 = 17.2 µM for human BTK in vitro and IC50 = 2.5 µM for recombinant BTK). Also inhibits Polo-like kinase in an ATP-competitive manner (IC50 = 10 µM and 61 µM for Plx1 and Plk3, respectively), and displays antitumor properties. Does not affect the enzymatic activity of other protein tyrosine kinases, including EGFR, HCK, IRK JAK1, and JAK3 even at concentrations of 278 µM. Enhances the chemosensitivity of BTK-positive B-lineage leukemia cells to ceramide- and vincristine-induced apoptosis.
      FormLight brown solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number62004-35-7
      Chemical formulaC₁₁H₈Br₂N₂O₂
      Structure formulaStructure formula
      Purity≥97% by HPLC
      SolubilityDMSO (200 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesUckun, F.M., et al. 2006. Bioorg. Med. Chem. In press.
      Mahajan, S., et al. 1999. J. Biol. Chem. 274, 9587.
      Vassilev, A., et al. 1999. J. Biol. Chem. 274, 1646.
      Citation
    • Sarah L Doyle, Caroline A Jefferies and Luke A O'Neill. (2005) Bruton's tyrosine kinase is involved in p65-mediated transactivation and phosphorylation of p65 on serine 536 during NF-B activation by LPS. Journal of Biological Chemistry 280, 23496-23501.
      		•